WikiFX

Rispondi

In my experience as a trader considering brokers like Gleneagle, determining the exact trading costs for instruments such as the US100 index is an important step before committing any funds. From the detailed information available on Gleneagle, I notice that while there is clear disclosure of fees for ASX equities and exchange-traded derivatives—typically 1.1% of transaction value with specific minimums and maximums—the fees for OTC products, which would generally include CFDs on indices like the US100, are not explicitly listed. Instead, these are referenced as being available within the Product Disclosure Statements (PDS) specific to each product. Personally, I take a conservative approach when faced with this kind of fee structure. The lack of up-front, detailed public information about OTC index trading costs means I would need to obtain and carefully review the relevant PDS directly from Gleneagle before trading. This ensures I fully understand all potential costs, including spreads, commissions, and any overnight financing or rollover charges. Given the regulatory oversight by ASIC, I generally have greater trust in the accuracy and transparency of fee disclosures, but I wouldn't proceed without first clarifying these costs directly. For me, the clarity and total transparency of trading costs are non-negotiable, especially before dealing in major indices.